Health Canada approves Merck’s etanercept biosimilar for new indications

Published date23 September 2020
Subject MatterMerck,Prescription Drugs,Biosimilars,Pharmaceutical Industry
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT